Smooth muscle in tissue remodeling and hyper-reactivity: Airways and arteries

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 1, 2013, Pages 13-23

  Rydell Törmänen, Kristina ^a   Risse, Paul André ^b   Kanabar, Varsha ^c   Bagchi, Rushita ^d   Czubryt, Michael P ^d   Johnson, Jill R ^e  

^a LUND UNIVERSITY   (Sweden)

^b MCGILL UNIVERSITY   (Canada)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF MANITOBA   (Canada)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Airway smooth muscle; Animal models; Asthma; Chronic obstructive pulmonary disease; Pulmonary hypertension; Vascular smooth muscle

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; CHEMOKINE; CYCLINE; DESMIN; ENDOTHELIN 1; EOTAXIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GELATINASE B; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HERMES ANTIGEN; HYALURONIDASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; KI 67 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCROTALINE; MYOSIN; OVALBUMIN; PLATELET DERIVED GROWTH FACTOR; RANTES; REACTIVE OXYGEN METABOLITE; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

AIRWAY; AIRWAY OBSTRUCTION; AIRWAY SMOOTH MUSCLE; ARTICLE; ASTHMA; AUTOPHAGY; BLOOD VESSEL TONE; BRONCHIECTASIS; BRONCHOSCOPY; BRONCHUS BIOPSY; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DISEASE SEVERITY; EXTRACELLULAR MATRIX; HUMAN; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; LUNG FIBROSIS; MEDIATOR; MESENCHYMAL STEM CELL; MOLECULAR DYNAMICS; MORPHOGENESIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PULMONARY HYPERTENSION; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASE; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE;

AIRWAY REMODELING; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CELL PROLIFERATION; HUMANS; HYPERTENSION, PULMONARY; HYPERTROPHY; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84873172114     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.04.003     Document Type: Article

References (187)

1. Macklin C.C. The musculature of the bronchi and lungs: a retrospect. Can Med Assoc J 1929, 20:404.
2. Ebina M., Yaegashi H., Takahashi T., Motomiya M., Tanemura M. Distribution of smooth muscles along the bronchial tree. A morphometric study of ordinary autopsy lungs. Am Rev Respir Dis 1990, 141:1322-1326.
3. James A., Carroll N. Airway smooth muscle in health and disease; methods of measurement and relation to function. Eur Respir J 2000, 15:782-789.
4. Alvarez D.F., Huang L., King J.A., ElZarrad M.K., Yoder M.C., Stevens T. Lung microvascular endothelium is enriched with progenitor cells that exhibit vasculogenic capacity. Am J Physiol Lung Cell Mol Physiol 2008, 294:L419-L430.
5. Guyton A.C., Hall J.E. Textbook of medical physiology 2000, Saunders, Philadelphia. 10th ed.
6. Lim L.H., Bochner B.S., Wagner E.M. Leukocyte recruitment in the airways: an intravital microscopic study of rat tracheal microcirculation. Am J Physiol Lung Cell Mol Physiol 2002, 282:L959-L967.
7. Majesky M.W. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 2007, 27:1248-1258.
8. Sainz J., Al Haj Zen A., Caligiuri G., Demerens C., Urbain D., Lemitre M., et al. Isolation of "side population" progenitor cells from healthy arteries of adult mice. Arterioscler Thromb Vasc Biol 2006, 26:281-286.
9. Topouzis S., Majesky M.W. Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta. Dev Biol 1996, 178:430-445.
10. Sparrow M.P., Weichselbaum M., McCray P.B. Development of the innervation and airway smooth muscle in human fetal lung. Am J Respir Cell Mol Biol 1999, 20:550-560.
11. Weaver M., Batts L., Hogan B.L. Tissue interactions pattern the mesenchyme of the embryonic mouse lung. Dev Biol 2003, 258:169-184.
12. Yang Y., Palmer K.C., Relan N., Diglio C., Schuger L. Role of laminin polymerization at the epithelial mesenchymal interface in bronchial myogenesis. Development 1998, 125:2621-2629.
13. Yang Y., Relan N.K., Przywara D.A., Schuger L. Embryonic mesenchymal cells share the potential for smooth muscle differentiation: myogenesis is controlled by the cell's shape. Development 1999, 126:3027-3033.
14. Woodcock-Mitchell J., White S., Stirewalt W., Periasamy M., Mitchell J., Low R.B. Myosin isoform expression in developing and remodeling rat lung. Am J Respir Cell Mol Biol 1993, 8:617-625.
15. deMello D.E., Sawyer D., Galvin N., Reid L.M. Early fetal development of lung vasculature. Am J Respir Cell Mol Biol 1997, 16:568-581.
16. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180.
17. Hirschi K.K., Rohovsky S.A., Beck L.H., Smith S.R., D'Amore P.A. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ Res 1999, 84:298-305.
18. Pepicelli C.V., Lewis P.M., McMahon A.P. Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr Biol 1998, 8:1083-1086.
19. Shu W., Jiang Y.Q., Lu M.M., Morrisey E.E. Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development 2002, 129:4831-4842.
20. Yuan B., Li C., Kimura S., Engelhardt R.T., Smith B.R., Minoo P. Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. Dev Dyn 2000, 217:180-190.
21. Reynolds P.R., Mucenski M.L., Le Cras T.D., Nichols W.C., Whitsett J.A. Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem 2004, 279:37124-37132.
22. Yamashita J., Itoh H., Hirashima M., Ogawa M., Nishikawa S., Yurugi T., et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000, 408:92-96.
23. Jostarndt-Fogen K., Djonov V., Draeger A. Expression of smooth muscle markers in the developing murine lung: potential contractile properties and lineal descent. Histochem Cell Biol 1998, 110:273-284.
24. Low R.B., White S.L. Lung smooth muscle differentiation. Int J Biochem Cell Biol 1998, 30:869-883.
25. Low R.B., Mitchell J., Woodcock-Mitchell J., Rovner A.S., White S.L. Smooth-muscle myosin heavy-chain SM-B isoform expression in developing and adult rat lung. Am J Respir Cell Mol Biol 1999, 20:651-657.
26. Rensen S.S., Thijssen V.L., De Vries C.J., Doevendans P.A., Detera-Wadleigh S.D., Van Eys G.J. Expression of the smoothelin gene is mediated by alternative promoters. Cardiovasc Res 2002, 55:850-863.
27. Morrisey E.E., Ip H.S., Tang Z., Lu M.M., Parmacek M.S. GATA-5: a transcriptional activator expressed in a novel temporally and spatially-restricted pattern during embryonic development. Dev Biol 1997, 183:21-36.
28. Kalinichenko V.V., Lim L., Shin B., Costa R.H. Differential expression of forkhead box transcription factors following butylated hydroxytoluene lung injury. Am J Physiol Lung Cell Mol Physiol 2001, 280:L695-L704.
29. Barnes P.J. Neural control of human airways in health and disease. Am Rev Respir Dis 1986, 134:1289-1314.
30. Carstairs J.R., Nimmo A.J., Barnes P.J. Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am Rev Respir Dis 1985, 132:541-547.
31. Onorato D.J., Demirozu M.C., Breitenbucher A., Atkins N.D., Chediak A.D., Wanner A. Airway mucosal blood flow in humans. Response to adrenergic agonists. Am J Respir Crit Care Med 1994, 149:1132-1137.
32. Black J.L., Salome C., Yan K., Shaw J. The action of prazosin and propylene glycol on methoxamine-induced bronchoconstriction in asthmatic subjects. Br J Clin Pharmacol 1984, 18:349-353.
33. Snashall P.D., Boother F.A., Sterling G.M. The effect of alpha-adrenoreceptor stimulation on the airways of normal and asthmatic man. Clin Sci Mol Med 1978, 54:283-289.
34. Brieva J., Wanner A. Adrenergic airway vascular smooth muscle responsiveness in healthy and asthmatic subjects. J Appl Physiol 2001, 90:665-669.
35. McFadden E.R. Hypothesis: exercise-induced asthma as a vascular phenomenon. Lancet 1990, 335:880-883.
36. Roffel A.F., Elzinga C.R., Van Amsterdam R.G., De Zeeuw R.A., Zaagsma J. Muscarinic M2 receptors in bovine tracheal smooth muscle: discrepancies between binding and function. Eur J Pharmacol 1988, 153:73-82.
37. Roffel A.F., Elzinga C.R., Zaagsma J. Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm Pharmacol 1990, 3:47-51.
38. Vincken W., van Noord J.A., Greefhorst A.P., Bantje T.A., Kesten S., Korducki L., et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 2002, 19:209-216.
39. Peters S.P., Kunselman S.J., Icitovic N., Moore W.C., Pascual R., Ameredes B.T., et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010, 363:1715-1726.
40. Walch L., Norel X., Leconte B., Gascard J.P., Brink C. Cholinergic control of human and animal pulmonary vascular tone. Therapie 1999, 54:99-102.
41. Barnes P.J. Muscarinic receptors in airways: recent developments. J Appl Physiol 1990, 68:1777-1785.
42. 3muscarinic receptors mediate acetylcholine-induced pulmonary vasodilation in pulmonary hypertension. Biosci Trends 2010, 4:260-266.
43. Barnes P.J. Histamine and serotonin. Pulm Pharmacol Ther 2001, 14:329-339.
44. Clarke D.L., Dakshinamurti S., Larsson A.K., Ward J.E., Yamasaki A. Lipid metabolites as regulators of airway smooth muscle function. Pulm Pharmacol Ther 2009, 22:426-435.
45. Norel X. Prostanoid receptors in the human vascular wall. ScientificWorldJournal 2007, 7:1359-1374.
46. Sakata K., Dahlen S.E., Back M. The contractile action of leukotriene B4 in the guinea-pig lung involves a vascular component. Br J Pharmacol 2004, 141:449-456.
47. Schmidt D., Rabe K.F. The role of leukotrienes in the regulation of tone and responsiveness in isolated human airways. Am J Respir Crit Care Med 2000, 161:S62-S67.
48. Hallstrand T.S., Henderson W.R. Role of leukotrienes in exercise-induced bronchoconstriction. Curr Allergy Asthma Rep 2009, 9:18-25.
49. Back M., Bu D.X., Branstrom R., Sheikine Y., Yan Z.Q., Hansson G.K. Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. Proc Natl Acad Sci U S A 2005, 102:17501-17506.
50. Parameswaran K., Radford K., Fanat A., Stephen J., Bonnans C., Levy B.D., et al. Modulation of human airway smooth muscle migration by lipid mediators and Th-2 cytokines. Am J Respir Cell Mol Biol 2007, 37:240-247.
51. Jeffery P.K. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001, 164:S28-S38.
52. Bai T.R., Knight D.A. Structural changes in the airways in asthma: observations and consequences. Clin Sci (Lond) 2005, 108:463-477.
53. Meyrick B., Reid L. Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression. Am J Pathol 1980, 100:151-178.
54. Lalich J.J., Merkow L. Pulmonary arteritis produced in rat by feeding Crotalaria spectabilis. Lab Invest 1961, 10:744-750.
55. Durmowicz A.G., Hofmeister S., Kadyraliev T.K., Aldashev A.A., Stenmark K.R. Functional and structural adaptation of the yak pulmonary circulation to residence at high altitude. J Appl Physiol 1993, 74:2276-2285.
56. Rabinovitch M., Gamble W., Nadas A.S., Miettinen O.S., Reid L. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol 1979, 236:H818-H827.
57. Stenmark K.R., Mecham R.P. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol 1997, 59:89-144.
58. Okada K., Tanaka Y., Bernstein M., Zhang W., Patterson G.A., Botney M.D. Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol 1997, 151:1019-1025.
59. Hemnes A.R., Zaiman A., Champion H.C. PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation. Am J Physiol Lung Cell Mol Physiol 2008, 294:L24-L33.
60. Reinhardt A.K., Bottoms S.E., Laurent G.J., McAnulty R.J. Quantification of collagen and proteoglycan deposition in a murine model of airway remodelling. Respir Res 2005, 6:30.
61. Temelkovski J., Hogan S.P., Shepherd D.P., Foster P.S., Kumar R.K. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998, 53:849-856.
62. Swirski F.K., D'Sa A., Kianpour S., Inman M.D., Stampfli M.R. Prolonged ovalbumin exposure attenuates airway hyperresponsiveness and T cell function in mice. Int Arch Allergy Immunol 2006, 141:130-140.
63. Van Hove C.L., Maes T., Joos G.F., Tournoy K.G. Prolonged inhaled allergen exposure can induce persistent tolerance. Am J Respir Cell Mol Biol 2007, 36:573-584.
64. Kelly M.M., Leigh R., Bonniaud P., Ellis R., Wattie J., Smith M.J., et al. Epithelial expression of profibrotic mediators in a model of allergen-induced airway remodeling. Am J Respir Cell Mol Biol 2005, 32:99-107.
65. Fattouh R., Pouladi M.A., Alvarez D., Johnson J.R., Walker T.D., Goncharova S., et al. House dust mite facilitates ovalbumin-specific allergic sensitization and airway inflammation. Am J Respir Crit Care Med 2005, 172:314-321.
66. Cates E.C., Fattouh R., Wattie J., Inman M.D., Goncharova S., Coyle A.J., et al. Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism. J Immunol 2004, 173:6384-6392.
67. Johnson J.R., Wiley R.E., Fattouh R., Swirski F.K., Gajewska B.U., Coyle A.J., et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med 2004, 169:378-385.
68. Berlin A.A., Hogaboam C.M., Lukacs N.W. Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma. Lab Invest 2006, 86:557-565.
69. Hogaboam C.M., Blease K., Mehrad B., Steinhauser M.L., Standiford T.J., Kunkel S.L., et al. Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol 2000, 156:723-732.
70. Samarasinghe A.E., Hoselton S.A., Schuh J.M. A comparison between intratracheal and inhalation delivery of Aspergillus fumigatus conidia in the development of fungal allergic asthma in C57BL/6 mice. Fungal Biol 2011, 115:21-29.
71. Le Cras T.D., Acciani T.H., Mushaben E.M., Kramer E.L., Pastura P.A., Hardie W.D., et al. Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthma. Am J Physiol Lung Cell Mol Physiol 2011, 300:L414-L421.
72. Johnson J.R., Roos A., Berg T., Nord M., Fuxe J. Chronic respiratory aeroallergen exposure in mice induces epithelial-mesenchymal transition in the large airways. PloS One 2011, 6:e16175.
73. Rubio M.L., Sanchez-Cifuentes M.V., Ortega M., Peces-Barba G., Escolar J.D., Verbanck S., et al. N-acetylcysteine prevents cigarette smoke induced small airways alterations in rats. Eur Respir J 2000, 15:505-511.
74. Wright J.L., Postma D.S., Kerstjens H.A., Timens W., Whittaker P., Churg A. Airway remodeling in the smoke exposed guinea pig model. Inhal Toxicol 2007, 19:915-923.
75. Botelho F.M., Bauer C.M., Finch D., Nikota J.K., Zavitz C.C., Kelly A., et al. IL-1alpha/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PloS One 2011, 6:e28457.
76. Bento A.M., Hershenson M.B. Airway remodeling: potential contributions of subepithelial fibrosis and airway smooth muscle hypertrophy/hyperplasia to airway narrowing in asthma. Allergy Asthma Proc 1998, 19:353-358.
77. Hamid Q., Cosio M., Lim S. Inflammation and remodeling in chronic obstructive pulmonary disease. J Allergy Clin Immunol 2004, 114:1479-1481.
78. Pepe C., Foley S., Shannon J., Lemiere C., Olivenstein R., Ernst P., et al. Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol 2005, 116:544-549.
79. Regamey N., Ochs M., Hilliard T.N., Muhlfeld C., Cornish N., Fleming L., et al. Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2008, 177:837-843.
80. Hays S.R., Ferrando R.E., Carter R., Wong H.H., Woodruff P.G. Structural changes to airway smooth muscle in cystic fibrosis. Thorax 2005, 60:226-228.
81. Huber F.K., Koessler K.K. The pathology of bronchial asthma. Arch Intern Med 1922, 30:689-760.
82. Jarjour N.N., Peters S.P., Djukanovic R., Calhoun W.J. Investigative use of bronchoscopy in asthma. Am J Respir Crit Care Med 1998, 157:692-697.
83. Benayoun L., Druilhe A., Dombret M.C., Aubier M., Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003, 167:1360-1368.
84. Bai T.R., Cooper J., Koelmeyer T., Pare P.D., Weir T.D. The effect of age and duration of disease on airway structure in fatal asthma. Am J Respir Crit Care Med 2000, 162:663-669.
85. Woodruff P.G., Dolganov G.M., Ferrando R.E., Donnelly S., Hays S.R., Solberg O.D., et al. Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med 2004, 169:1001-1006.
86. Ebina M., Takahashi T., Chiba T., Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis 1993, 148:720-726.
87. Goldsmith A.M., Bentley J.K., Zhou L., Jia Y., Bitar K.N., Fingar D.C., et al. Transforming growth factor-beta induces airway smooth muscle hypertrophy. Am J Respir Cell Mol Biol 2006, 34:247-254.
88. McWhinnie R., Pechkovsky D.V., Zhou D., Lane D., Halayko A.J., Knight D.A., et al. Endothelin-1 induces hypertrophy and inhibits apoptosis in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2007, 292:L278-L286.
89. Zhou D., Zheng X., Wang L., Stelmack G., Halayko A.J., Dorscheid D., et al. Expression and effects of cardiotrophin-1 (CT-1) in human airway smooth muscle cells. Br J Pharmacol 2003, 140:1237-1244.
90. Halayko A.J., Kartha S., Stelmack G.L., McConville J., Tam J., Camoretti-Mercado B., et al. Phophatidylinositol-3 kinase/mammalian target of rapamycin/p70S6K regulates contractile protein accumulation in airway myocyte differentiation. Am J Respir Cell Mol Biol 2004, 31:266-275.
91. Johnson P.R., Roth M., Tamm M., Hughes M., Ge Q., King G., et al. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 2001, 164:474-477.
92. Hassan M., Jo T., Risse P.A., Tolloczko B., Lemiere C., Olivenstein R., et al. Airway smooth muscle remodeling is a dynamic process in severe long-standing asthma. J Allergy Clin Immun 2010, 125:1037-1045. e3.
93. Benayoun L., Letuve S., Druilhe A., Boczkowski J., Dombret M.C., Mechighel P., et al. Regulation of peroxisome proliferator-activated receptor gamma expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling. Am J Respir Crit Care Med 2001, 164:1487-1494.
94. Ramos-Barbon D., Presley J.F., Hamid Q.A., Fixman E.D., Martin J.G. Antigen-specific CD4+ T cells drive airway smooth muscle remodeling in experimental asthma. J Clin Invest 2005, 115:1580-1589.
95. Ramos-Barbon D., Fraga-Iriso R., Brienza N.S., Montero-Martinez C., Verea-Hernando H., Olivenstein R., et al. T Cells localize with proliferating smooth muscle alpha-actin+ cell compartments in asthma. Am J Respir Crit Care Med 2010, 182:317-324.
96. Herszberg B., Ramos-Barbon D., Tamaoka M., Martin J.G., Lavoie J.P. Heaves, an asthma-like equine disease, involves airway smooth muscle remodeling. J Allergy Clin Immunol 2006, 118:382-388.
97. Leclere M., Lavoie-Lamoureux A., Gelinas-Lymburner E., David F., Martin J.G., Lavoie J.P. Effect of antigenic exposure on airway smooth muscle remodeling in an equine model of chronic asthma. Am J Respir Cell Mol Biol 2011, 45:181-187.
98. Leclere M., Lavoie-Lamoureux A., Martin J.G., Lavoie J.P. Inhaled corticosteroids accelerate the reversal of airway smooth muscle remodeling in an equine model of chronic asthma. Am J Respir Crit Care Med 2010, 181:A2302.
99. Fujita H., Chalubinski M., Rhyner C., Indermitte P., Meyer N., Ferstl R., et al. Claudin-1 expression in airway smooth muscle exacerbates airway remodeling in asthmatic subjects. J Allergy Clin Immunol 2011, 127:1612-1621. e8.
100. Amishima M., Munakata M., Nasuhara Y., Sato A., Takahashi T., Homma Y., et al. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. Am J Respir Crit Care Med 1998, 157:1907-1912.
101. Takeyama K., Fahy J.V., Nadel J.A. Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. Am J Respir Crit Care Med 2001, 163:511-516.
102. Polosa R., Puddicombe S.M., Krishna M.T., Tuck A.B., Howarth P.H., Holgate S.T., et al. Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects. J Allergy Clin Immunol 2002, 109:75-81.
103. Tschumperlin D.J., Dai G., Maly I.V., Kikuchi T., Laiho L.H., McVittie A.K., et al. Mechanotransduction through growth-factor shedding into the extracellular space. Nature 2004, 429:83-86.
104. Hirota N., Risse P.A., Novali M., McGovern T., Al-Alwan L., McCuaig S., et al. Histamine may induce airway remodeling through release of epidermal growth factor receptor ligands from bronchial epithelial cells. FASEB J 2012, 26:1704-1716.
105. McGovern T., Risse P.A., Tsuchiya K., Hassan M., Frigola G., Martin J.G. LTD induces HB-EGF-dependent CXCL8 release through EGFR activation in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2010, 299:L808-L815.
106. Takeda N., Sumi Y., Prefontaine D., Al Abri J., Al Heialy N., Al-Ramli W., et al. Epithelium-derived chemokines induce airway smooth muscle cell migration. Clin Exp Allergy 2009, 39:1018-1026.
107. Halwani R., Al-Abri J., Beland M., Al-Jahdali H., Halayko A.J., Lee T.H., et al. CC and CXC chemokines induce airway smooth muscle proliferation and survival. J Immunol 2011, 186:4156-4163.
108. Malavia N.K., Raub C.B., Mahon S.B., Brenner M., Panettieri R.A., George S.C. Airway epithelium stimulates smooth muscle proliferation. Am J Respir Cell Mol Biol 2009, 41:297-304.
109. Kuo P.L., Hsu Y.L., Huang M.S., Chiang S.L., Ko Y.C. Bronchial epithelium-derived IL-8 and RANTES increased bronchial smooth muscle cell migration and proliferation by Kruppel-like factor 5 in areca nut-mediated airway remodeling. Toxicol Sci 2011, 121:177-190.
110. Bara I., Ozier A., Tunon de Lara J.M., Marthan R., Berger P. Pathophysiology of bronchial smooth muscle remodelling in asthma. Eur Respir J 2010, 36:1174-1184.
111. Chang Y., Al-Alwan L., Risse P.A., Roussel L., Rousseau S., Halayko A.J., et al. TH17 cytokines induce human airway smooth muscle cell migration. J Allergy Clin Immunol 2011, 127:1046-1053. e1-2.
112. Al-Alwan L., Baglole C., Chang Y., Eidelman D.H., Hamid Q.J.G.M. Th17 associated cytokines promote human airway smooth muscle cell proliferation. Am J Respir Crit Care Med 2011, 183:A3601.
113. Hackett T.L., Warner S.M., Stefanowicz D., Shaheen F., Pechkovsky D.V., Murray L.A., et al. Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. Am J Respir Crit Care Med 2009, 180:122-133.
114. D'Antoni M.L., Torregiani C., Ferraro P., Michoud M.C., Mazer B., Martin J.G., et al. Effects of decorin and biglycan on human airway smooth muscle cell proliferation and apoptosis. Am J Physiol Lung Cell Mol Physiol 2008, 294:L764-L771.
115. D'Antoni M.L., Risse P.A., Ferraro P., Martin J.G., Ludwig M.S. Effects of decorin and biglycan on human airway smooth muscle cell adhesion. Matrix Biol 2011.
116. Hirst S.J., Twort C.H., Lee T.H. Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype. Am J Respir Cell Mol Biol 2000, 23:335-344.
117. Kaur D., Hollins F., Saunders R., Woodman L., Sutcliffe A., Cruse G., et al. Airway smooth muscle proliferation and survival is not modulated by mast cells. Clin Exp Allergy 2010, 40:279-288.
118. Alkhouri H., Hollins F., Moir L.M., Brightling C.E., Armour C.L., Hughes J.M. Human lung mast cells modulate the functions of airway smooth muscle cells in asthma. Allergy 2011, 66:1231-1241.
119. Woodman L., Siddiqui S., Cruse G., Sutcliffe A., Saunders R., Kaur D., et al. Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-beta 1. J Immunol 2008, 181:5001-5007.
120. Cohen M.D., Ciocca V., Panettieri R.A. TGF-beta 1 modulates human airway smooth-muscle cell proliferation induced by mitogens. Am J Respir Cell Mol Biol 1997, 16:85-90.
121. Hawker K.M., Johnson P.R., Hughes J.M., Black J.L. Interleukin-4 inhibits mitogen-induced proliferation of human airway smooth muscle cells in culture. Am J Physiol 1998, 275:L469-L477.
122. Risse P.A., Jo T., Suarez F., Hirota N., Tolloczko B., Ferraro P., et al. Interleukin-13 inhibits proliferation and enhances contractility of human airway smooth muscle cells without change in contractile phenotype. Am J Physiol Lung Cell Mol Physiol 2011, 300:L958-L966.
123. Espinosa K., Bosse Y., Stankova J., Rola-Pleszczynski M. CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J Allergy Clin Immunol 2003, 111:1032-1040.
124. Riess A., Wiggs B., Verburgt L., Wright J.L., Hogg J.C., Pare P.D. Morphologic determinants of airway responsiveness in chronic smokers. Am J Respir Crit Care Med 1996, 154:1444-1449.
125. Kuwano K., Bosken C.H., Pare P.D., Bai T.R., Wiggs B.R., Hogg J.C. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993, 148:1220-1225.
126. Bhattacharya J. Lung neovascularization: a tale of two circulations. Am J Physiol Lung Cell Mol Physiol 2008, 294:L417-L418.
127. Chin K.M., Rubin L.J. Pulmonary arterial hypertension. J Am Coll Cardiol 2008, 51:1527-1538.
128. Humbert M. Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology. Eur Respir Rev 2010, 19:59-63.
129. Morrell N.W., Adnot S., Archer S.L., Dupuis J., Jones P.L., MacLean M.R., et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009, 54:S20-S31.
130. Huang J.B., Liu Y.L., Sun P.W., Lv X.D., Bo K., Fan X.M. Novel strategy for treatment of pulmonary arterial hypertension: enhancement of apoptosis. Lung 2010, 188:179-189.
131. Corris P.A., Gibson G.J. Asthma presenting as cor pulmonale. Br Med J (Clin Res Ed) 1984, 288:389-390.
132. Griffin J.T., Kass I., Hoffman M.S. Cor pulmonale associated with symptoms and signs of asthma in children. Pediatrics 1959, 24:54-64.
133. Miyamoto T., Kass I., Hoffman M.S. Electrocardiogram in asthmatic children. Circulation 1960, 22:90-95.
134. Rothman A., Kulik T.J. Pulmonary hypertension and asthma in two patients with congenital heart disease. Am J Dis Child 1989, 143:977-979.
135. Walton C.H., Penner D.W., Wilt J.C. Sudden death from asthma. Can Med Assoc J 1951, 64:95-102.
136. Tormanen K.R., Uller L., Persson C.G., Erjefalt J.S. Allergen exposure of mouse airways evokes remodeling of both bronchi and large pulmonary vessels. Am J Respir Crit Care Med 2005, 171:19-25.
137. Rydell-Tormanen K., Uller L., Erjefalt J.S. Remodeling of extra-bronchial lung vasculature following allergic airway inflammation. Respir Res 2008, 9:18.
138. Daley E., Emson C., Guignabert C., de Waal Malefyt R., Louten J., Kurup V.P., et al. Pulmonary arterial remodeling induced by a Th2 immune response. J Exp Med 2008.
139. Torsney E., Xu Q. Resident vascular progenitor cells. J Mol Cell Cardiol 2011, 50:304-311.
140. Armulik A., Genove G., Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 2011, 21:193-215.
141. Bai T.R. Evidence for airway remodeling in chronic asthma. Curr Opin Allergy Clin Immunol 2010, 10:82-86.
142. Juniantito V., Izawa T., Yuasa T., Ichikawa C., Yamamoto E., Kuwamura M., et al. Immunophenotypical analyses of myofibroblasts in rat excisional wound healing: possible transdifferentiation of blood vessel pericytes and perifollicular dermal sheath cells into myofibroblasts. Histol Histopathol 2012, 27:515-527.
143. Sakao S., Tatsumi K. Vascular remodeling in pulmonary arterial hypertension: multiple cancer-like pathways and possible treatment modalities. Int J Cardiol 2011, 147:4-12.
144. Beghe B., Bazzan E., Baraldo S., Calabrese F., Rea F., Loy M., et al. Transforming growth factor-beta type II receptor in pulmonary arteries of patients with very severe COPD. Eur Respir J 2006, 28:556-562.
145. Peinado V.I., Barbera J.A., Ramirez J., Gomez F.P., Roca J., Jover L., et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol 1998, 274:L908-L913.
146. Green F.H., Butt J.C., James A.L., Carroll N.G. Abnormalities of the bronchial arteries in asthma. Chest 2006, 130:1025-1033.
147. Price L.C., Wort S.J., Perros F., Dorfmuller P., Huertas A., Montani D., et al. Inflammation in pulmonary arterial hypertension. Chest 2012, 141:210-221.
148. Sazonova O.V., Lee K.L., Isenberg B.C., Rich C.B., Nugent M.A., Wong J.Y. Cell-cell interactions mediate the response of vascular smooth muscle cells to substrate stiffness. Biophys J 2011, 101:622-630.
149. Burgess J.K., Ceresa C., Johnson S.R., Kanabar V., Moir L.M., Nguyen T.T., et al. Tissue and matrix influences on airway smooth muscle function. Pulm Pharmacol Ther 2009, 22:379-387.
150. Moir L.M., Burgess J.K., Black J.L. Transforming growth factor beta 1 increases fibronectin deposition through integrin receptor alpha 5 beta 1 on human airway smooth muscle. J Allergy Clin Immunol 2008, 121:1034-1039. e4.
151. Vlahos R., Stewart A.G. Interleukin-1alpha and tumour necrosis factor-alpha modulate airway smooth muscle DNA synthesis by induction of cyclo-oxygenase-2: inhibition by dexamethasone and fluticasone propionate. Br J Pharmacol 1999, 126:1315-1324.
152. Hultgardh-Nilsson A., Durbeej M. Role of the extracellular matrix and its receptors in smooth muscle cell function: implications in vascular development and disease. Curr Opin Lipidol 2007, 18:540-545.
153. Fernandes D.J., Bonacci J.V., Stewart A.G. Extracellular matrix, integrins, and mesenchymal cell function in the airways. Curr Drug Targets 2006, 7:567-577.
154. Roberts C.R., Burke A.K. Remodelling of the extracellular matrix in asthma: proteoglycan synthesis and degradation. Can Respir J 1998, 5:48-50.
155. Laitinen A., Altraja A., Kampe M., Linden M., Virtanen I., Laitinen L.A. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997, 156:951-958.
156. Bousquet J., Chanez P., Lacoste J.Y., White R., Vic P., Godard P., et al. Asthma: a disease remodeling the airways. Allergy 1992, 47:3-11.
157. Raines E.W. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease. Int J Exp Pathol 2000, 81:173-182.
158. Araujo B.B., Dolhnikoff M., Silva L.F., Elliot J., Lindeman J.H., Ferreira D.S., et al. Extracellular matrix components and regulators in the airway smooth muscle in asthma. Eur Respir J 2008, 32:61-69.
159. Klagas I., Goulet S., Karakiulakis G., Zhong J., Baraket M., Black J.L., et al. Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD. Eur Respir J 2009, 34:616-628.
160. Yick C.Y., Ferreira D.S., Annoni R., von der Thusen J.H., Kunst P.W., Bel E.H., et al. Extracellular matrix in airway smooth muscle is associated with dynamics of airway function in asthma. Allergy 2012, 67:552-559.
161. Brewster C.E., Howarth P.H., Djukanovic R., Wilson J., Holgate S.T., Roche W.R. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990, 3:507-511.
162. Westergren-Thorsson G., Chakir J., Lafreniere-Allard M.J., Boulet L.P., Tremblay G.M. Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects. Int J Biochem Cell Biol 2002, 34:1256-1267.
163. Johnson P.R. Role of human airway smooth muscle in altered extracellular matrix production in asthma. Clin Exp Pharmacol Physiol 2001, 28:233-236.
164. Johnson P.R., Black J.L., Carlin S., Ge Q., Underwood P.A. The production of extracellular matrix proteins by human passively sensitized airway smooth-muscle cells in culture: the effect of beclomethasone. Am J Respir Crit Care Med 2000, 162:2145-2151.
165. Potter-Perigo S., Baker C., Tsoi C., Braun K.R., Isenhath S., Altman G.M., et al. Regulation of proteoglycan synthesis by leukotriene d4 and epidermal growth factor in bronchial smooth muscle cells. Am J Respir Cell Mol Biol 2004, 30:101-108.
166. Eble J.A., Niland S. The extracellular matrix of blood vessels. Curr Pharm Des 2009, 15:1385-1400.
167. Niland S., Eble J.A. Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation. J Oncol 2012, 2012:125278.
168. Freyer A.M., Johnson S.R., Hall I.P. Effects of growth factors and extracellular matrix on survival of human airway smooth muscle cells. Am J Respir Cell Mol Biol 2001, 25:569-576.
169. Chan V., Burgess J.K., Ratoff J.C., O'Connor B.J., Greenough A., Lee T.H., et al. Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med 2006, 174:379-385.
170. Peng Q., Lai D., Nguyen T.T., Chan V., Matsuda T., Hirst S.J. Multiple beta 1 integrins mediate enhancement of human airway smooth muscle cytokine secretion by fibronectin and type I collagen. J Immunol 2005, 174:2258-2264.
171. Dekkers B.G., Schaafsma D., Tran T., Zaagsma J., Meurs H. Insulin-induced laminin expression promotes a hypercontractile airway smooth muscle phenotype. Am J Respir Cell Mol Biol 2009, 41:494-504.
172. Tran T., Halayko A.J. Extracellular matrix and airway smooth muscle interactions: a target for modulating airway wall remodelling and hyperresponsiveness?. Can J Physiol Pharmacol 2007, 85:666-671.
173. Papakonstantinou E., Karakiulakis G. The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance. Br J Pharmacol 2009, 157:1111-1127.
174. Gill S., Wight T.N., Frevert C.W. Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection. Anat Rec (Hoboken) 2010, 293:968-981.
175. Adair-Kirk T.L., Senior R.M. Fragments of extracellular matrix as mediators of inflammation. Int J Biochem Cell Biol 2008, 40:1101-1110.
176. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
177. Shi F., Qiu C., Qi H., Peng W. shRNA targeting beta1-integrin suppressed proliferative aspects and migratory properties of airway smooth muscle cells. Mol Cell Biochem 2012, 361:111-121.
178. Dekkers B.G., Maarsingh H., Meurs H., Gosens R. Airway structural components drive airway smooth muscle remodeling in asthma. Proc Am Thorac Soc 2009, 6:683-692.
179. Caswell P.T., Spence H.J., Parsons M., White D.P., Clark K., Cheng K.W., et al. Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments. Dev Cell 2007, 13:496-510.
180. Johnson P.R., Burgess J.K., Underwood P.A., Au W., Poniris M.H., Tamm M., et al. Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism. J Allergy Clin Immunol 2004, 113:690-696.
181. Kanabar V., Karner L.C., Simcock D.E., Mahn K., Nguyen T.T.B., Cousins D.J., et al. Integrin gene profiling in airway smooth muscle from asthmatics. Proc Am Thorac Soc 2007, 4:A302.
182. Umesh A., Paudel O., Cao Y.N., Myers A.C., Sham J.S. Alteration of pulmonary artery integrin levels in chronic hypoxia and monocrotaline-induced pulmonary hypertension. J Vasc Res 2011, 48:525-537.
183. Tatler A.L., John A.E., Jolly L., Habgood A., Porte J., Brightling C., et al. Integrin alphavbeta5-mediated TGF-beta activation by airway smooth muscle cells in asthma. J Immunol 2011, 187:6094-6107.
184. Santambrogio M., Valdembri D., Serini G. Increasing traffic on vascular routes. Mol Aspects Med 2011, 32:112-122.
185. Lever R., Page C. Glycosaminoglycans, airways inflammation and bronchial hyperresponsiveness. Pulm Pharmacol Ther 2001, 14:249-254.
186. Sadowitz B., Seymour K., Gahtan V., Maier K.G. The role of hyaluronic acid in atherosclerosis and intimal hyperplasia. J Surg Res 2012, 173:e63-e72.
187. Manabe R., Tsutsui K., Yamada T., Kimura M., Nakano I., Shimono C., et al. Transcriptome-based systematic identification of extracellular matrix proteins. Proc Natl Acad Sci U S A 2008, 105:12849-12854.